| scholarly article | Q13442814 |
| P50 | author | Ibrahim Elsayed | Q57053266 |
| P2093 | author name string | Ahmed Hassen Elshafeey | |
| Aly Ahmed Abdelbary | |||
| P2860 | cites work | World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects | Q28300546 |
| Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability | Q30832367 | ||
| Selection of reliable reference genes for qPCR studies on chondroprotective action | Q33275599 | ||
| Development of an oral rutin nanocrystal formulation | Q33396383 | ||
| Modeling and comparison of dissolution profiles | Q34215811 | ||
| Nanosuspensions: a promising drug delivery strategy. | Q35826447 | ||
| Nanosuspensions in drug delivery | Q35876031 | ||
| Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q₁₀ as naked nanocrystals | Q36404933 | ||
| Nanosizing--oral formulation development and biopharmaceutical evaluation | Q36865278 | ||
| A novel preparation method for drug nanocrystals and characterization by ultrasonic spray-assisted electrostatic adsorption | Q37233330 | ||
| Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. | Q37249988 | ||
| Nanocrystal technology, drug delivery and clinical applications. | Q37319937 | ||
| Development of lipid nanoparticles of diacerein, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effects | Q39224874 | ||
| Optimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability function | Q41650065 | ||
| Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation | Q42923477 | ||
| Comparison of nanomilling and coprecipitation on the enhancement of in vitro dissolution rate of poorly water-soluble model drug aripiprazole | Q44639623 | ||
| Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. | Q45121177 | ||
| Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. | Q45989955 | ||
| Advantages of celecoxib nanosuspension formulation and transformation into tablets. | Q46019773 | ||
| Solubility increases associated with crystalline drug nanoparticles: methodologies and significance | Q46188911 | ||
| Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine | Q46582675 | ||
| Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement | Q46837639 | ||
| Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method | Q47758963 | ||
| Statistical optimization of medium components and growth conditions by response surface methodology to enhance phenol degradation by Pseudomonas putida. | Q50959372 | ||
| Third international conference on harmonization of technical requirements for registration of pharmaceuticals for human use--a toxicologist's perspective. | Q53366676 | ||
| A screening study of surface stabilization during the production of drug nanocrystals | Q59285630 | ||
| Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation | Q73701609 | ||
| Micronization: a method of improving the bioavailability of poorly soluble drugs | Q74727268 | ||
| Clinical pharmacokinetics of diacerein | Q77634758 | ||
| Dissolution rate studies. II. Dissolution of particles under conditions of rapid agitation | Q79452313 | ||
| Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000 | Q83748227 | ||
| Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization | Q84991817 | ||
| Effect of fixed aqueous layer thickness of polymeric stabilizers on zeta potential and stability of aripiprazole nanosuspensions | Q87407226 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 2943-2953 | |
| P577 | publication date | 2014-06-17 | |
| P1433 | published in | International Journal of Nanomedicine | Q6051502 |
| P1476 | title | Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers | |
| P478 | volume | 9 |
| Q37527859 | A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization. |
| Q38661401 | A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies. |
| Q42204107 | Are We Using Slow-Acting Symptomatic Chondroprotective Drugs Conscious Enough? |
| Q64984261 | Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and Challenges. |
| Q40970686 | Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation |
| Q48105405 | Enhancement of pharmacokinetic and pharmacological behavior of ocular dorzolamide after factorial optimization of self-assembled nanostructures. |
| Q52647214 | Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation. |
| Q64972547 | Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition. |
| Q58738523 | Oleic Acid Nanovesicles of Minoxidil for Enhanced Follicular Delivery |
| Q89909601 | Optimization, characterization and in vitro/vivo evaluation of azilsartan nanocrystals |
| Q49874284 | Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone |
| Q43216548 | Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration |
| Q58698851 | Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein |
| Q64087626 | Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation |
Search more.